Launch week offerEnds in00h00m00s

Alicia Llorente

Senior scientist

Oslo University Hospital
Country flagNorway

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (10)

Year:

2026

Year:

2025

Altered cellular metabolism is a well-established hallmark of cancer. Although most studies have focused on the metabolism of glucose and glutamine, the upregulation of lipid metabolism is also frequent in cells undergoing oncogenic transformation. In fact, cancer cells need to meet the enhanced demand of plasma membrane synthesis and energy production to support their proliferation. Moreover, lipids are precursors of signaling molecules, termed lipid mediators, which play a role in shaping the tumor microenvironment. Recent methodological advances in lipid analysis have prompted studies aimed at investigating the whole lipid content of a sample (lipidome) to unravel the complexity of lipid changes in cancer patient biofluids. This review focuses on the application of mass spectrometry-based lipidomics for the discovery of cancer biomarkers. Here, we have summarized the main lipid alteration in cancer patients’ biofluids and uncovered their potential use for the early detection of the disease and treatment selection. We also discuss the advantages of using biofluid-derived extracellular vesicles as a platform for lipid biomarker discovery. These vesicles have a molecular signature that is a fingerprint of their originating cells. Hence, the analysis of their molecular cargo has emerged as a promising strategy for the identification of sensitive and specific biomarkers compared to the analysis of the unprocessed biofluid.

Year:

2023

Year:

2022

Year:

2022

Extracellular vesicles induced by exercise have emerged as potential mediators of tissue crosstalk. Extracellular vesicles and their cargo miRNAs have been linked to dysglycemia and obesity in animal models, but their role in humans is unclear. Aim The aim of the study was to characterize the miRNA content in plasma extracellular vesicle isolates after acute and long‐term exercise and to study associations between extracellular vesicle miRNAs, mRNA expression in skeletal muscle and adipose tissue, and cardiometabolic risk factors. Methods Sedentary men with or without dysglycemia and overweight underwent an acute bicycle test and a 12‐week exercise intervention with extensive metabolic phenotyping. Gene expression in m. vastus lateralis and subcutaneous adipose tissue was measured with RNA sequencing. Extracellular vesicles were purified from plasma with membrane affinity columns or size exclusion chromatography. Results Extracellular vesicle miRNA profiling revealed a transient increase in the number of miRNAs after acute exercise. We identified miRNAs, such as miR‐652‐3p, that were associated to insulin sensitivity and adiposity. By performing explorative association analyses, we identified two miRNAs, miR‐32‐5p and miR‐339‐3p, that were strongly correlated to an adipose tissue macrophage signature. Conclusion Numerous miRNAs in plasma extracellular vesicle isolates were increased by exercise, and several miRNAs correlated to insulin sensitivity and adiposity. Our findings warrant future studies to characterize exercise‐induced extracellular vesicles and cargo miRNA to clarify where exercise‐induced extracellular vesicles originate from, and to determine whether they influence metabolic health or exercise adaptation.

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (14)

Elena Martens-Uzunova

Assistant professor

Erasmus University Rotterdam

NETHERLANDS
View details

Luisa Pascucci

Professore Associato

University of Perugia

ITALY
View details

Aija Linē

Professor

University of Latvia

LATVIA
View details

Aija Klavina

Leading Researcher

Riga Stradiņš University

LATVIA
View details

Paolo Scarpelli

Associate Professor FSZ/SBIOL

University of Ostrava

CZECH REPUBLIC
View details

Manuel Ramirez-Garrastacho

Head engineer Proteomics

University of Oslo

NORWAY
View details

Ilaria Bellezza

University of Perugia

ITALY
View details

Marit Hjorth

University of Oslo

NORWAY
View details

Carolina Soekmadji

Commonwealth Scientific and Industrial Research Organisation

AUSTRALIA
View details

Francesca Fallarino

University of Perugia

ITALY
View details

Marco Gargaro

Assistant Professor

University of Perugia

ITALY
View details

Barbara Cellini

Associate professor

University of Perugia

ITALY
View details

Ilangko Balasingham

Prof. at Oslo University Hospital

Oslo University Hospital

NORWAY
View details

Milica Bozic

Principal Investigator

University Hospital Essen

GERMANY
View details